acquired
Stage
2004
Founded
1
Investors
About
Apitope was a clinical-stage biotechnology company developing novel peptide therapeutics, called 'apitopes', to treat autoimmune diseases such as multiple sclerosis and Graves' disease. Its proprietary technology platform generated highly specific, immunomodulatory peptides.
Explore Apitope's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.